Dr. Reddy's Laboratories Ltd. closed 13.36% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Shares of Dr Reddys Laboratories experienced a decline of 0.67% to Rs 1228.00 during today's trading session, accompanied by ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Dr. Reddy's Laboratories Ltd. closed 13.05% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Dr Reddys Laboratories shares experienced notable trading activity, with the price currently at Rs 1215.40, reflecting a 0.69 ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Dr. Reddys Laboratories stock opened higher on the NSE at Rs 1,196 and then surged to an intraday high of Rs 1,241. As of ...

Pharmaceutical firm Dr Reddy's Laboratories announced its quarterly results for the March 2024 quarter on Friday. The company reported a 22% year-on-year rise in consolidated net profit, reaching Rs 1 ...

Dr. Reddy's Laboratories added 3.34% to Rs 1,193.75 after the company reported a consolidated net profit of Rs 1,594 crore for the quarter ended March 2025 (Q4FY25), marking a 22% year-on-year ...

Indian equity benchmarks – BSE Sensex and NSE Nifty - are set to open higher today, tracking firm cues from Asian peers and ...

The sharp 250 basis points quarter-on-quarter decline in gross margin (the third consecutive sequential fall) reinforces ...